Fig. 8.
Effects of InvD1L-specific blocker fluphenazine (Flu) on dopamine- or SKF82958-mediated salivary gland acini dynamics. (A) Percentage increase in acini volume after various combined treatments. (B) Frequencies of acini observed for pumping/gating in each treatment. The data in A are the averages with s.e.m. for at least three biological replicates. The data in B are frequencies in observations of more than 18 acini for each data point. The data were analysed by an ANOVA–Tukey–Kramer HSD test (P=0.05).